Matthew C. Busch - Aug 14, 2023 Form 3 Insider Report for AMGEN INC (AMGN)

Signature
/s/ Matthew C. Busch
Stock symbol
AMGN
Transactions as of
Aug 14, 2023
Transactions value $
$0
Form type
3
Date filed
8/21/2023, 07:36 PM
Next filing
Nov 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AMGN Common Stock 4.6K Aug 14, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AMGN Nqso (Right to Buy) Aug 14, 2023 Common Stock 1.26K $177.46 Direct F3
holding AMGN Nqso (Right to Buy) Aug 14, 2023 Common Stock 1.48K $177.31 Direct F4
holding AMGN Nqso (Right to Buy) Aug 14, 2023 Common Stock 1.56K $236.36 Direct F5
holding AMGN Nqso (Right to Buy) Aug 14, 2023 Common Stock 1.09K $239.64 Direct F6
holding AMGN Nqso (Right to Buy) Aug 14, 2023 Common Stock 1.75K $230.92 Direct F7
holding AMGN Nqso (Right to Buy) Aug 14, 2023 Common Stock 2.51K $235.97 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 64 RSUs which will vest on 5/5/2024; 84 RSUs which will vest in installments of 41 on 4/30/2024 and 43 on 4/30/2025; 175 RSUs which will vest on 11/5/2023; 1,496 RSUs which will vest in installments of 493 on 11/5/2023, 494 on 11/5/2024 and 509 on 11/5/2025; 214 RSUs which will vest in installments of 70 on 5/2/2024, 71 on 5/2/2025, and 73 on 5/2/2026; and 296 RSUs which will vest in installments of 97 on 5/2/2025, 98 on 5/2/2026 and 101 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
F2 These shares include 126 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
F3 1,257 of these non-qualified stock options have vested and are exercisable.
F4 1,476 of these non-qualified stock options have vested and are exercisable.
F5 1,028 of these non-qualified stock options have vested and 530 will vest and become exercisable on 5/5/2024.
F6 358 of these non-qualified stock options have vested and the remaining options will vest and become exercisable in installments of 358 on 4/30/2024 and 370 on 4/30/2025.
F7 These non-qualified stock options will vest and become exercisable in two installments of 578 on 5/2/2024 and 5/2/2025 and one installment of 597 on 5/2/2026.
F8 These non-qualified stock options will vest and become exercisable in installments of 827 on 5/2/2025, 828 on 5/2/2026 and 853 on 5/2/2027.